Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
Crossref DOI link: https://doi.org/10.1038/s41598-018-23943-w
Published Online: 2018-04-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shinde, Prajakta
Fernandes, Sophia
Melinkeri, Sameer
Kale, Vaijayanti
Limaye, Lalita
Text and Data Mining valid from 2018-04-09
Version of Record valid from 2018-04-09
Article History
Received: 2 January 2018
Accepted: 22 March 2018
First Online: 9 April 2018
Competing Interests
: The authors declare no competing interests.